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ABSTRACT: Woodsmoke poses a significant health risk as a growing component of ambient air pollution in the United States. While there is a
long history of association between woodsmoke exposure and diseases of the respiratory, circulatory, and cardiovascular systems, recent evidence has linked woodsmoke exposure to cognitive dysfunction, including Alzheimer’s disease dementia. Alzheimer’s disease is a progressive
neurodegenerative disorder with largely idiopathic origins and no known cure. Here, we explore the growing body of literature which relates
woodsmoke-generated and ambient air pollution particulate matter exposure to Alzheimer’s disease (AD) onset or exacerbation, in the context
of an inflammation-centric view of AD. Epigenetic modifications, specifically changes in DNA methylation patterns, are well documented following woodsmoke exposure and have been shown to influence disease-favoring inflammatory cascades, induce oxidative stress, and modulate
the immune response in vitro, in vivo, and in humans following exposure to air pollution. Though the current status of the literature does not allow
us to draw definitive conclusions linking these events, this review highlights the need for additional work to fill gaps in our understanding of the
directionality, causality, and susceptibility throughout the life course.
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Background

Unfortunately, common methods of wildfire prevention (eg,
prescribed burning to reduce fuel sources) are themselves contributors of AWS air pollution. With mitigation measures factored in, US deaths directly attributed to WFS are still expected
to double as early as 2050.4 In addition to mortality, exposure
to TWS has been correlated with morbidities such as cancer,
cardiovascular disease, and respiratory syndromes. Recently,
AWS exposure has also been associated with central nervous
system (CNS) dysfunction, including Alzheimer’s disease
(AD) dementia.6
AD is a progressive neurodegenerative disorder characterized by hallmark pathological markers such as senile amyloidbeta (Aβ) plaques and neurofibrillary tau tangles (NFTs), as
well as neuroinflammation, synaptic dysfunction, and neuronal
cell death, which collectively results in marked cognitive
impairment.7 AD accounts for 50% to75% of all known
dementias.8 According to the Centers for Disease Control, AD
is the 5th leading cause of death among the elderly, impacting
nearly 5 million Americans over 65, a number which is expected
to triple by 2060.9 Despite advances in our understanding of
AD pathology, there remains no effective treatment or cure.
Because of this, research efforts have transitioned from a treatment approach to attempting preventative measures. While
this push to better understand etiology has resulted in the
characterization of a heritable subtype of AD, the majority of
cases remain idiopathic in nature.10 Identifying modifiable risk
factors and associated mechanisms could aid in the prevention
of AD and help curb the rising tide of the disease.

An estimated 9 out of 10 individuals live where air quality
exceeds World Health Organization guidelines.1 This is the
result of high levels of ambient air pollution (AAP) which is
made up of components from naturally occurring (ie, wildfires)
or anthropogenic (ie, traffic-related air pollution, prescribed
burns) sources. While airborne pollutants vary by source, season,
and location, it is well established that particulate matter (PM)
smaller than 2.5 µm in diameter (PM2.5) is of great importance
to human health due to penetration of lung alveoli.2 The toxic
potential of particles generated from different sources is likely
to be unique and thus it is important to independently consider
the health impacts and associated mechanisms of major sources.
Wildfire smoke (WFS) is demonstrated to be a major source of
AAP PM, contributing as much as 70% of PM2.5 in the western
United States (US) on days when regulatory limits are exceeded.3
Importantly, projections indicate that as early as the year 2100
WFS could derive greater than 50% of total PM2.5 for the entire
US.4 Alongside WFS, anthropogenic woodsmoke (AWS) has
been estimated to contribute between 56 to 77% of PM2.5 in
western communities in the winter.5 Geographical effects of
total woodsmoke (TWS: comprised of WFS and AWS) air pollution extend beyond immediate regions where biomass combustion occurs due to the ability of smoke particulate to travel
great distances.
The health burden associated with smoke exposure is of
concern as increased wildfire prevalence is expected with
warmer, drier environments concurrent with climate change.
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The molecular mechanisms that underlie the onset of morbidity following TWS exposure are not well understood, especially as they differ from total AAP exposure. One promising
theory is that combination of inflammation, oxidative stress,
and epigenetic modifications might link airborne pollutant
inhalation and subsequent disease pathogenesis. Several
reviews have been conducted which explore the potential for
environmental effect on epigenetic patterns to modify disease
pathogenesis, including AD.11-17 Additionally, reviews have
been conducted which explore the association between AAP
exposure and onset of AD or dementia.18-23 Very recently, a
review has assessed the effects of exposure to bushfire smoke
on brain health.24 Taken together, these existing articles demonstrate the growing body of literature which supports interplay between molecular mechanisms, including epigenetics,
which underlie disease onset and occur following air pollution
exposure. More work is needed to characterize the ability of
TWS constituents, individually or as a whole, to influence epigenetics mechanisms that underlie AD though recent publications have suggested the plausibility of this relationship.
Specifically, Wang et al.13 postulates that epigenetic modifications might help to explain the link between formaldehyde (a
component of TWS) exposure and subsequent onset of AD.
Traditional approaches to address the nature of this relationship have been largely siloed with public health researchers
reporting epidemiologic data, molecular biologists studying
epigenetics and pathological progression, and chemists or environmental scientists characterizing PM makeup and air pollution exposure events. However, recent cross-disciplinary efforts
have allowed for the emergence of a new perspective. Our
review seeks to explore existing literature and apply this novel
lens to better understand how exposure to TWS and molecular
mechanisms believed to be involved in AD onset are interrelated by referencing data from in vitro and in vivo models, as
well as data from human epidemiologic analyses. While others
have reviewed air pollution broadly, or traffic-related air pollution specifically, we here cite the expected increase in the contribution of wood smoke to cumulative ambient air pollution as
rationale which warrants evaluation of the status of the science
and identification of major gaps in knowledge regarding links
between TWS exposure and AD.

Total woodsmoke characterization

The most prevalent component of WFS by mass is PM2.5
which is composed of: sulfate, nitrate, ammonium, chloride,
elemental/organic carbon, and other air pollutants.25 These
components are subject to variation based on geographic location, season, and fuel source.3,26 Likewise, AWS contains highly
variable levels of air pollutants depending upon the fuel source,
conditions surrounding combustion,27,28 and the type of fire
actively burning (ie, smolder, active flame).29 Some groups have
described exposure assessment techniques that can be used to
distinguish between the contribution of diesel emissions or

woodsmoke to AAP30,31 As a result, reporting source apportionment of PM2.5 is essential to accurately assess implications
of exposure. Source apportionment studies provide strong evidence for the consideration of TWS as a unique contributor to
AAP.32 For example, data indicate that biomass combustion
including TWS more strongly correlates with respiratory disease compared to motor vehicle sources,33 whereas motor vehicle sources relative to AWS have been more strongly linked to
cancer risk.34 Importantly, AAP exposure in studies that do not
report source apportionment for PM2.5 may contain TWS pollutants depending on the location and season. Because of this,
some studies reporting AAP exposure data have been included
in this review.

Woodsmoke exposure

Determining how TWS-derived particles come into contact
with CNS tissue, or whether direct contact is necessary to
induce AD-related outcomes, remains a challenge associated
with this work (Figure 1). One potential for direct exposure is
through uptake during inhalation. While no studies have demonstrated this in models exposed to TWS PM, recent work has
documented the ability of iron soot, a product of biomass combustion, to enter the CNS directly via olfactory nerve bundles
and subsequently travel to the brain.51 Another potential pathway that has been proposed is that following TWS inhalation,
PM passes through the lung-blood barrier and drives systemic
inflammation, which leads to attenuation of the blood-brain
barrier (BBB). While this has not been demonstrated in studies of WFS-derived PM, there are reports of altered BBB permeability following AAP exposure.58,59 Additionally, AWS has
been demonstrated to activate the nuclear factor kappa B (NFkB) pathway as well as increase the release of tumor necrosis
factor alpha (TNF-α) in mouse peritoneal macrophages.56
This cascade leads to the systemic release of proinflammatory
cytokines (IL-1β, 6, 12, 18) and is known to regulate BBB
structural integrity.60 NF-kB mediated inflammation has also
been reported in the lung, blood, and brain following AAP
exposure in male wild-type (C57BL/6) mice.49 Collectively,
this demonstrates the potential for induction of systemic
inflammatory cascades, driven by inhalation exposure, to sufficiently increase BBB permeability which could allow TWS
particles to directly interact with neurons or microglia. While
this is an attractive theory, additional work is required to characterize the specific nature of TWS particle access to CNS tissue, or if an alternate indirect mechanism negates the need for
direct PM contact (ie, inflammatory mediators generated following inhalation of TWS particles travel to the brain and
drive AD pathogenesis).

Woodsmoke and neurodegeneration

Notwithstanding full elucidation of TWS PM toxicokinetics
related to CNS tissue, it is clear from the literature that both
AAP and AWS exposures are associated with increased AD
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Figure 1. Working model demonstrating potential direct (1a and b) or indirect route (2) of CNS exposure to Total Woodsmoke (TWS) PM, inflammationmediated progression of AD, and contribution to hallmark pathology. (1a) PM 2.5 enters the brain directly via the olfactory tract. (1b) PM2.5 enters the lung
during inhalation and crosses the lung blood barrier, entering into systemic inflammation and allowing direct access to the BBB. (2) PM 2.5 is inhaled,
phagocytosed by innate immune cells, and induces systemic inflammation which can indirectly affect the BBB. Exposure event subsequently attenuates
BBB integrity and CNS tissue becomes susceptible to exacerbation of AD pathology, neuroinflammation. While these pathways are discussed here as
independent, the true exposure route may be a combination of these pathways.
Abbreviations: Aβ, amyloid beta; CNS, central nervous system; AD, Alzheimer’s disease; BBB, blood-brain barrier; PM, particulate matter.
Image created using BioRender.com.

onset.6,35-37 Attempts to characterize molecular explanations
for AD onset have largely followed the thought that senile
plaques and NFTs are driving factors in pathogenesis.
Research published on this front has led to the development
of the “amyloid hypothesis,” which was held as the general
consensus surrounding AD onset for many years.61 Drug
design studies targeting various components in amyloid
hypothesis pathways have demonstrated little promise in
clinical trials. As such, a shift favoring other theories regarding disease origin has occurred.62 The emergence of an
inflammation-centric view of AD has demonstrated significant promise in recent years.63 Accordingly, we here assess
TWS influence on AD in this context.

While no literature currently demonstrates a clear causative
molecular mechanism to explain the correlation between either
TWS or AAP exposure and AD onset, there are many individual investigations that characterize inflammatory or cell
stress pathway activation following an exposure event. These
specific physiological changes are relevant to the pathogenesis
of AD and are summarized in Table 1. Studies assessing occupational health risks in firefighters have found that acute AWS
exposure is associated with systemic inflammation.38,39 Similar
observations have been made in mouse or cell models.49,50,55 Li
et. al.55 speculate that the mechanism underlying cellular toxicity following exposure-induced inflammation is linked to
mitochondrial dysfunction as evidenced by reactive oxygen

Model

Human (n = 1806)

Human (n = 871)

Human (n = 2340)

Human (n = 29 547)

Human (n = 12)

Human (n = 14)

Human (n = 21 548)

Human (n = 645)

Human (n = 998)

Human (n = 783)

Human (n = 646)

Human (n = 157)

Human (n = 8397)

3×Tg AD mouse (n = 10)

EFAD mouse (n = 10)

Author

Oudin et al.6

Wu et al.35

Li et al.36

Chang et al.37

Hejl et al.38

Unosson et al.39

Cerza et al.40

Lee et al.41

Younan et al.42

Guxens et al.43

Dai et al.44

Mostafavi et al.45

Gondalia et al.46

Jew et al.47

Cacciottolo et al.48

Adult and Elderly
Elderly
Adult and Elderly
Adult and Elderly
Adult
Adult
Elderly
Elderly
Elderly
In Utero
Elderly
Adult and Elderly
Adult and Elderly
Elderly
Adult

~12 y
5y
~12 y
1 mo
3h
~12 y
1 mo to 1 y
3y
Gestation
(9 mo)
1y
24 h
Daily and
monthly
2 wk
10-15 wk

Exposure
Timepoint

~15 y

Exposure
Duration

Whole-body

Whole-body

Estimated

Personal air
monitor

Estimated

Estimated

Estimated

Estimated

Estimated

Whole-body

Personal air
monitor

Estimated

Estimated

Estimated

Estimated

Exposure
Assessment/
Method

AAP (PM2.5)

AAP (PM0.1)

AAP (PM10,
PM2.5)

AAP (PM2.5,
PM0.3)

AAP (PM2.5)

AAP (NO2,
PM10, PM2.5)

AAP (PM2.5)

AAP (PM2.5)

AAP (NO2, O3,
PM10, PM2.5)

AWS (PM1)

AWS (CO,
PM2.5)

AAP (NO2, CO)

AAP (PM2.5)

AAP (PM10,
O3)

AWS (PM2.5)

Exposure
Type

(Continued)

AAP exposure correlates with worsened AD pathological
phenotype, dementia risk

AAP exposure correlates with cognitive dysfunction

AAP exposure correlates with differential DNA methylation,
including in AD-relevant genes

Acute AAP exposure correlates with changes in DNA
methylation

PM2.5 exposure correlates with changes in epigenome-wide
DNA methylation

Fetal AAP exposure correlates with abnormal brain
development

AAP exposure correlates with cognitive dysfunction

AAP exposure correlates with neuropsychiatric symptoms in
AD, MCI

AAP exposure correlates with dementia hospitalization

Acute AWS exposure correlates with pathologic CV
symptoms

Acute AWS exposure correlates with increase in IL-8

NO2 and CO exposure correlates with dementia risk

AAP exposure correlated with allergic rhinitis onset, AD risk

AAP exposure correlates with AD, VaD risk

Woodsmoke PM2.5 correlates with AD risk

Outcomes relevant to review topic

Table 1. Citations from primary literature articles reviewed which assess AAP or TWS exposure in humans, animal models, or cell lines. Numbers correspond to the manuscript bibliography.
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24 h
5 and 24 h
24 h
30 min-24 h
5 wk

Primary hippocampal
mouse cells

Human bronchial epithelial
cells

Primary hippocampal
mouse cells

Peritoneal macrophage
mouse cells

Human bronchial epithelial
cells

Ku et al.49

Pardo et al.50

Li et al.55

Leonard et al.56

Hesselbach
et al.57

Culture media

Culture media

Culture media

Culture media

Culture media

Culture media

Estimated

Whole-body

Whole-body

Nose only

Oropharyngeal
aspiration

Exposure
Assessment/
Method

AWS (PM2.5)

AWS

AAP (PM2.5)

Wood tar
aerosols

AAP (PM2.5)

AAP (PM4)

WFS (PM2.5)

AAP (PM0.1)

Iron-soot
aerosol

Wood tar
aerosols

AAP (PM2.5)

Exposure
Type

AWS exposure resulted in a global hypomethlyation,
disease-relevant differential methylation

AWS exposure correlates with oxidative stress, NF-kB
mediated inflammation

AAP exposure correlates with inflammatory, diseasefavorable phenotype

AWS component exposure correlates with cytotoxicity in
vitro

AAP exposure correlates with systemic inflammation,
cognitive dysfunction

AAP exposure resulted in microglial activation, PARP-1
mediated Aβ levels in hippocampus

Early life WFS exposure correlates with peripheral immune
cell dysfunction later in life

Fetal AAP exposure correlates with cognitive dysfunction in
males

Iron-soot particles found in olfactory nerve tracts, olfactory
bulb

AWS component exposure correlates with inflammation in
vivo

AAP exposure correlates with systemic inflammation,
cognitive dysfunction

Outcomes relevant to review topic

Abbreviations: AD, Alzheimer’s disease; AAP, ambient air pollution; AWS, anthropogenic woodsmoke; WFS, wildfire smoke; VaD, Vascular dementia; MCI, mild cognitive impairment; PM, particulate matter.

Adult cells

Adult cells

Perinatal neurons

Adult cells

Perinatal neurons

Elderly Mice for
ex vivo

24 h

3×Tg AD mouse (ex vivo)
Neuro2A mouse cells

Jang et al.54

Perinatal

3y

Rhesus macaques (n = 25)

Black et al.53

Perinatal

2 wk

C57/BL6 mouse (n = 10)

Cory-Slechta
et al.52

Adult

5 wk

C57/BL6 mouse (n = 20)

Hopkins et al.51

Adult

Single
Exposure

C57/BL6 mouse (n = 6)

Pardo et al.50

Exposure
Timepoint

Adult

C57/BL6 mouse (n = 6)

Ku et al.49

Exposure
Duration

4 wk

Model

Author

Table 1. (Continued)
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species (ROS) formation and oxidative stress. This is plausible
given that ROS and NF-kB are known regulators of one
another64 and have been implicated in AD risk.65 Alternatively,
AAP exposed mouse cells display overexpression of cyclooxygenase-2 (COX-2) mediated by ROS formation following
NF-kB activation. COX-2 is known to aggravate inflammation and plays a role in worsening AD pathology.66 Both of
these molecular mechanisms represent a potential pathway for
exposure-induced inflammation or cell stress cascades to result
in cellular damage or cytotoxicity.
In addition to AD risk, chronic AAP exposure has been correlated with exacerbation of symptoms and increased incidence
of hospitalization for those with dementia.40 Lee et al.41 found
that, in patients with mild cognitive impairment (MCI) or AD,
high levels of exposure to AAP PM2.5 worsens neuropsychiatric symptoms. Furthermore, elderly females with elevated residential AAP PM2.5 exposure exhibit accelerated declines in
executive functions, including immediate recall and new learning.42 Changes in cognition not only decrease the quality of life
for the patient suffering from AD but also extend the impact
of AD on society. Worsening neuropsychiatric state and decline
in executive function increases caregiver burden67 and furthers
the economic impact of AD.68 These implications strengthen
the need for more extensive experimentation surrounding
TWS exposure in the context of AD.
Complementing epidemiologic data suggesting a link
between exposure to environmental air pollutants and altered
AD phenotype, animal and cell models have been employed to
investigate potential mechanistic links (Table 1). To date, these
experiments are limited exclusively to the analysis of cumulative AAP47,48,54 but future studies should investigate PM from
unique sources, namely TWS or even individual PM generating events—prescribed burns, residential wood burning, wildfires. Two different transgenic AD mouse models69,70 have
been used to explore AAP exposure effect on dementia onset or
progression. In both cases, increased tissue pathological load
and eventual clinical presentation worsened following inhalation of the toxicant. These data demonstrate that exposure
events have the potential to exacerbate the clinical progression
of AD, independent of genetic predisposition to the disease.
In addition to identifying how TWS PM mechanistically
influences CNS function, establishing windows of susceptibility, particularly during early life will be important for mitigating disease risk. Data suggests that human in utero exposure to
AAP may significantly delay neurological development and
impair cognitive function.43 Similarly, mouse pups exposed to
AAP at timepoints representative of third trimester pregnancy
in humans were found to display decrement in learning and
memory.52 Both deficits in CNS structure and executive function are believed to have an association with the risk of AD
onset or worsened disease phenotype.71 Accordingly, TWSinduced CNS dysfunction could be partly explained by the
developmental origins of health and disease (DOHaD)

hypothesis72 which posits that early life exposure events can
shape disease risk throughout the lifespan. There is a significant lack of existing research to explore the cumulative effects
of exposure throughout the life course. We have identified 4
time points which seem to have distinct outcomes when
assessed individually for exposure (Figure 2). Our understanding regarding windows of susceptibility to TWS will hopefully
be expanded in the coming years following efforts to prospectively track health outcomes following major wildfire events
such as the Camp Fire of 2018 which took place in California
(eg, WHAT-Now-California study being led by researchers at
UC Davis).
Some limited information from the animal literature suggests that early life exposure to TWS may impact inflammatory processes implicated in AD risk. Non-human primates
exposed to WFS-derived PM in infancy presented with modulation of immune response measured using peripheral blood
mononuclear cells (PBMCs) during adolescence.53 This
included a dampened response to toll-like receptor (TLR)
stimulation and downstream signaling through NF-kB.
Important in the context of AD, microglia expressing TLRs
(TLR2, 4, and 9)73 are thought to help recognize and phagocytose neurotoxic pathology (ie, Aβ plaques).74 Attenuation of
innate immune response may occur in microglia as observed in
PBMCs, and if so, there is potential for this to mediate TWSderived PM effect on AD etiology. Furthermore, it is known
that PBMCs are recruited to the brain when microglia become
overwhelmed in AD.75 If parenchymal Aβ load or TWS
PM-induced neuroinflammation cause sufficient strain on
microglia clearance ability, the recruitment of PBMCs that
have been “damaged” by TWS exposure (as seen in the rhesus
macaque following exposure) might significantly hinder the
ability to clear parenchymal AD pathology and result in neuronal death. This hypothesized mechanism of macrophagerelated AD disease risk has not been fully demonstrated and
thus remains speculative.

Woodsmoke and epigenetics

Another appealing mechanism commonly evaluated as a conduit between exposure and disease is epigenetic alterations.
Epigenetics can be defined as heritable features that affect gene
expression, without altering the DNA sequence directly. The
most well-characterized epigenetic modification is DNA
methylation, which is the addition of a methyl group to a 5’
cytosine in a cytosine-guanine dinucleotide (CpG). DNA
hypermethylation at CpG islands is typically associated with
repression of gene transcription. Leading up to and shortly
after birth, waves of DNA methylation patterns are established
in a region or gene-specific fashion, and these patterns are
inherently cell-specific.76 Unlike the genetic sequence, DNA
methylation patterns are believed to remain plastic throughout
the life span.77 Differential DNA methylation has been demonstrated to be especially impactful at in utero or perinatal time
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Figure 2. Representative time points of TWS exposure with potential for individual exposure events or cumulative effects to result in ultimate age-related
phenotype.
Abbreviation: AD, Alzheimer’s disease.
Image created using BioRender.com.

points,78 in support of the DOHaD hypothesis. Further work
is necessary to implicate these timepoints in AD risk following
TWS exposure, though early AAP exposure has been demonstrated to affect neural developmental trajecotry.79 The dynamic
nature of DNA methylation presents a way for environmental
exposure to alter functional protein levels and affect system
physiology. Recently, novel data has associated epigenetic modification with the onset of AD.80,81 Notably, global DNA hypomethylation—often linked to chromatin stability—has been
implicated in AD onset.82 Review articles14,15 have explored
potential reasons why CNS tissue is susceptible to DNA methylation changes citing reasons such as the large number of
genes involved in the complex regulation of CNS development
and maintenance relative to other tissues. Indeed, it has also
been reported that in studies of AD discordance between
monozygotic twins, differential DNA methylation profiles can
be detected in PBMCs.83 While the directionality of this phenomenon was not definitive in that study, this demonstrates
novel evidence in support of further characterization of DNA
methylation profiles in the context of AD risk. Notably, DNA
methylation also serves as a potential target for therapeutic
interventions84 and could ultimately help to mitigate disease
risk.
Changes in DNA methylation following AAP and TWS
exposure have been well demonstrated.44-46,57 While the differential DNA methylation patterns reported here have not
been demonstrated to have a definitive causative effect on AD,
they are involved in the inflammatory pathways that are currently held as central mechanisms of disease onset and/or progression (Table 1). For instance, differential methylation of the
gene coding for cAMP-regulated phosphoprotein 21 (ARPP21)
was associated with acute AAP PM exposure.46 Aberrant
expression of ARPP21 occurs with altered entorhinal cortical
(EC) thickness which is known to correlate with worsened
cognitive performance and exacerbation of AD progression.85
In another study assessing epigenome-wide methylation of
buffy coat DNA, AAP PM2.5 was associated with methylation

of genes involved in immune cell maturation and function.44
Additionally, differential CpG methylation in human peripheral blood samples has been related to immune system modulation with respect to 24-h AAP PM2.5 levels.45 Innate immune
system activation has been extensively studied as a potential
link between peripheral inflammation and neuroinflammation
in neurodegenerative disease73 and theories surrounding exposure-induced aberrant innate immune response contribution to
neurodegeneration have been addressed in this review.

Discussion

Here, we review the growing body of literature regarding the
impact of air pollution on public health, and more specifically
linking TWS exposure to AD onset. This focused evaluation is
necessary and timely given the dramatic shift that is expected in
air pollution source contribution from industrial/automobile to
TWS. We have cited examples of plausible molecular mechanisms whereby exposure-induced differential DNA methylation
may alter AD risk, exacerbate other disease-relevant processes,
and ultimately influence the phenotypic presentation.
Notably, comparing health outcomes from studies assessing
effects of AAP, WFS, AWS, and traffic-related air pollution
(TRAP) presents a major challenge because the composition of
exposure constituents is inherently highly variable from sample
to sample. Even comparing results from 2 studies that claim to
measure the same source of pollution (eg, WFS) is problematic
because of the complexity introduced by weather, geography,
and fuel source. Also, many studies are conducted using estimates of PM exposure gathered from sparsely located governmental sites due to limitations in more localized data gathering
methods which can include instrument availability or cost as
well as participant recruitment. It is important to consider that
there are inconsistencies in the way that estimated exposure
models are generated86 and these methods may be particularly
problematic in the rural west due to low sampler density.
Additional consideration should also be given to the effect of
TWS “ageing,” or the change in chemical composition as

Epigenetics Insights 

8

smoke spreads outward from the fire source.87 These factors
highlight a need for better characterization of the toxicity of
individual TWS components and mixtures under multiple
environmental conditions. Our review also revealed inconsistencies in the way comorbidities and relevant disease status were
recorded. Thus, when conducting future population health
studies, researchers must consider health status and relevant
AD risk factors in the population to improve interpretability
and reproducibility of findings.
The implication that modifiable environmental exposures
could drive disease onset or other aspects of pathogenesis raises
the potential for interventions by which to ameliorate AD risk.
At a population level, heightened awareness of the health
threat posed by smoke exposure, coupled with increased efforts
to reduce climate change and continued monitoring of air
quality, would aid in the prevention of TWS generating events.
At the individual level, some have posited that the impact of
environmental toxicant exposure and subsequent development
of dementia could be reversible.22 If DNA methylation is
determined to be a mechanistic driver of pathogenesis, then the
modification of disease-favoring states could reduce lifelong
disease risk or heritability. Considering the link between TWS
exposure and inflammation, a potential therapeutic might have
broader applications to more neurodegenerative disorders in
addition to AD.
Candidate gene methylation patterns represent potential
disease biomarkers, especially if they could be detected in an
accessible sample (eg, blood) before the progression of debilitating pathology. Mounting evidence exists to suggest that
peripheral lymphocytes demonstrate AD-like inflammatory
profiles before the onset of cognitive decline and independently
of senile plaque or NFT pathology.88,89 In this way, exploration
of differential DNA methylation patterns following exposure
events in AD-relevant gene regions using peripheral samples
(ie, buffy-coat DNA) may be useful as a minimally invasive
diagnostic biomarker even if there is not found to be a causal
involvement in neurodegenerative pathogenesis.
Model systems that complement epidemiological studies
will be key to bolstering our understanding of the influence of
woodsmoke on neuronal health. Future work using animal and
cell models should investigate these molecular changes with
varying study design endpoints to assess the efficacy of prediction regarding the ultimate disease phenotype. The relative
scale of aging for rodents coupled with the ease of genetic
manipulation will allow more rapid exploration of different
exposure durations and constituents, at varying time points, to
generate data in support of a causal relationship.

Conclusion

The directionality and causality of the complex relationship
between TWS exposure and the molecular underpinnings of
neurodegenerative disease are not clear, yet predictions that
TWS exposure will increase nationwide in the coming decades
warrants further efforts to this end. The model proposed here

demonstrates multiple ways that TWS exposure may influence
AD onset and/or progression including through peripheral
modulation of innate immune signaling, attenuation of the
blood-brain barrier, and ultimately neuroinflammation leading
to the parenchymal susceptibility to hallmark AD pathologies.
Exposure timepoint, duration, and composition of TWS PM
may distinctively influence the aforementioned pathways.
TWS exposure events warrant further independent study from
other AAP sources in the context of molecular mechanisms,
specifically aberrant DNA methylation, underlying neuroinflammation, and AD.
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